Antibiotic regimens tailored by clinical pharmacist supported by intensivist enhance rational use of antibiotics

References

• Hisham M, Sivakumar MN, Veerasekar G. Impact of clinical pharmacist in an Indian intensive care unit. Indian J Crit Care Med. 2016;20(2):78–83. doi: 10.4103/0972-5229.175931
   PubMedGoogle Scholar
• Horn E, Jacobi J. The critical care clinical pharmacist: evolution of an essential team member. Crit Care Med. 2006;34(3 Suppl):S46–51. doi: 10.1097/01.CCM.0000199990.68341.33
   PubMed Web of Science ®Google Scholar
• Abousheishaa AA, Sulaiman AH, Huri HZ, et al. Global scope of hospital pharmacy practice: a scoping review. Healthcare (Basel). 2020;8(2):143. doi: 10.3390/healthcare8020143
   PubMedGoogle Scholar
• Tavakoli FC, Adams-Sommer VL, Frendak LS, et al. Assessing the impact of a clinical pharmacist in a postsurgical inpatient population. J Pharm Pract. 2022;35(1):32–37. doi: 10.1177/0897190020938196
   PubMed Web of Science ®Google Scholar
• Leache L, Aquerreta I, Aldaz A, et al. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients. Res Social Adm Pharm. 2020;16(9):1285–1289. doi: 10.1016/j.sapharm.2019.07.006
   PubMed Web of Science ®Google Scholar
• De Waele J, De Bus L. How to treat infections in a surgical intensive care unit. BMC Infect Dis. 2014;14(1):193. doi: 10.1186/1471-2334-14-193
   PubMedGoogle Scholar
• Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis. 2008;47(Suppl 1):S3–13. doi: 10.1086/590061
   PubMed Web of Science ®Google Scholar
• De Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229. doi: 10.1016/S0895-4356(02)00585-1
   PubMed Web of Science ®Google Scholar
• Sozen H, Gonen I, Sozen A, et al. Application of ATC/DDD methodology to evaluate of antibiotic use in a general hospital in Turkey. Ann Clin Microbiol Antimicrob. 2013;12(1):23. doi: 10.1186/1476-0711-12-23
   PubMedGoogle Scholar
• Magedanz L, Silliprandi EM, dos Santos RP. Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study. Int J Clin Pharm. 2012;34(2):290–294. doi: 10.1007/s11096-012-9621-7
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases Society of America. Surg Infect (Larchmt). 2010;11(1):79–109. doi: 10.1089/sur.2009.9930
   PubMed Web of Science ®Google Scholar
• Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24(9):699–706. doi: 10.1086/502278
   PubMed Web of Science ®Google Scholar
• Scaglione F, Paraboni L. Pharmacokinetics/Pharmacodynamics of antibacterials in the intensive care unit: setting appropriate dosing regimens. Int J Antimicrob Agents. 2008;32(4):294–301. doi: 10.1016/j.ijantimicag.2008.03.015
   PubMed Web of Science ®Google Scholar
• Cappelletty D, Jacobs D. Evaluating the impact of a pharmacist’s absence from an antimicrobial stewardship team. Am J Health Syst Pharm. 2013;70(12):1065–1069. doi: 10.2146/ajhp120482
   PubMed Web of Science ®Google Scholar
• Baral P, Hann K, Pokhrel B, et al. Annual consumption of parenteral antibiotics in a tertiary hospital of Nepal, 2017–2019: a cross-sectional study. Public Health Action. 2021;11(Suppl 1):52–57. doi: 10.5588/pha.21.0043
   PubMed Web of Science ®Google Scholar
• Li Q, Tong Y, Wang H, et al. Origin of sepsis associated with the short-term mortality of patients: a retrospective study using the eICU collaborative research database. Int J Gen Med. 2021;14:10293–10301. doi: 10.2147/IJGM.S345050
   PubMed Web of Science ®Google Scholar
• Saokaew S, Maphanta S, Thangsomboon P. Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit. Pharm Pract (Granada). 2009;7(2):81–87. doi: 10.4321/S1886-36552009000200003
   PubMedGoogle Scholar
• Klopotowska JE, Kuiper R, van Kan HJ, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14(5):R174. doi: 10.1186/cc9278
   PubMed Web of Science ®Google Scholar
• MacLaren R, Bond CA, Martin SJ, et al. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36(12):3184–3189. doi: 10.1097/CCM.0b013e31818f2269
   PubMed Web of Science ®Google Scholar
• Shen J, Sun Q, Zhou X, et al. Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. Int J Clin Pharm. 2011;33(6):929–933. doi: 10.1007/s11096-011-9577-z
   PubMed Web of Science ®Google Scholar
• Bedini A, De Maria N, Del Buono M, et al. Antimicrobial stewardship in a gastroenterology department: impact on antimicrobial consumption, antimicrobial resistance and clinical outcome. Dig Liver Dis. 2016;48(10):1142–1147. doi: 10.1016/j.dld.2016.06.023
   PubMedGoogle Scholar
• Lee H, Ryu K, Sohn Y, et al. Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: a systematic review and meta-analysis. Crit Care Med. 2019;47(9):1243–1250. doi: 10.1097/CCM.0000000000003830
   PubMed Web of Science ®Google Scholar
• Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals. Pharmacotherapy. 1999;19(12):1354–1362. doi: 10.1592/phco.19.18.1354.30893
   PubMed Web of Science ®Google Scholar
• Kucukarslan SN, Corpus K, Mehta N, et al. Evaluation of a dedicated pharmacist staffing model in the medical intensive care unit. Hosp Pharm. 2013;48(11):922–930. doi: 10.1310/hpj4811-922
   PubMedGoogle Scholar
• Salman B, Al-Hashar A, Al-Khirbash A, et al. Clinical and cost implications of clinical pharmacist interventions on antimicrobial use at Sultan Qaboos University Hospital in Oman. Int J Infect Dis. 2021;109:137–141. doi: 10.1016/j.ijid.2021.07.002
   PubMed Web of Science ®Google Scholar
• Lucca JM, Ramesh M, Narahari GM, et al. Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital. J Pharmacol Pharmacother. 2012;3(3):242–247. doi: 10.4103/0976-500X.99422
   PubMedGoogle Scholar
• Kalam MA, Shano S, Afrose S, et al. Antibiotics in the community during the COVID-19 pandemic: a qualitative study to understand users’ perspectives of antibiotic seeking and consumption behaviors in Bangladesh. Patient Prefer Adherence. 2022;16:217–233. doi: 10.2147/PPA.S345646
   PubMed Web of Science ®Google Scholar